Cystic Fibrosis  >>  andecaliximab (GS-5745)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
andecaliximab (GS-5745) / Gilead
NCT02759562 / 2015-002192-23: Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis

Terminated
2b
6
Europe, RoW
Andecaliximab, GS-5745, Placebo
Gilead Sciences
Cystic Fibrosis
07/17
07/17

Download Options